Caffeine decreases exhaled nitric oxide

Bruce, C.; Yates, D. H.; Thomas, P. S.
April 2002
Thorax;Apr2002, Vol. 57 Issue 4, p361
Academic Journal
Background: Caffeine is known to inhibit phosphodiesterases, to mobilise intracellular calcium, and to act as an antagonist at adenosine receptors, all of which can potentially alter nitric oxide (NO) production. It was therefore hypothesised that caffeine may alter exhaled NO (eNO) levels. Methods: In a randomised, single blind, crossover manner, 12 normal subjects consumed either (1) coffee and a placebo capsule, (2) decaffeinated coffee and a capsule of 200 mg caffeine, or (3) decaffeinated coffee and a placebo capsule. Serum caffeine levels were measured at baseline and 1 hour later. Exhaled NO levels were also measured at baseline and each hour For 4 hours. Results: A significant percentage fall in mean (SE) eNO from baseline was seen 1 hour after either caffeinated coffee or a caffeine capsule when compared with placebo (13.5 (4.0)%, p=0.009 and 19.0 (3.8)%, p=0.001, respectively). Conclusion: Caffeine causes a significant decrease in eNO which will need to be considered when designing trials to measure eNO levels. The mechanism may be via adenosine receptor antagonism or by altering levels of cGMP.


Related Articles

  • Caffeine's Vascular Mechanisms of Action. Echeverri, Darío; Montes, Félix R.; Cabrera, Mariana; Galán, Angélica; Prieto, Angélica // International Journal of Vascular Medicine;2010, p1 

    Caffeine is themost widely consumed stimulating substance in the world. It is found in coffee, tea, soft drinks, chocolate, and many medications. Caffeine is a xanthine with various effects andmechanisms of action in vascular tissue. In endothelial cells, it increases intracellular calcium...

  • Tadalafil for Pulmonary Arterial Hypertension. Abrams, Jonathan // Clinical Cardiology Alert;Sep2009, Vol. 28 Issue 9, p67 

    The article discusses a study on the effectiveness of tadalafil, an oral phosphodiesterase (PDE) inhibitor, in treating pulmonary arterial hypertension (PAH), conducted by G. Galie and colleagues. Findings revealed that 40 milligrams (mg) of the drug was the only dose effective against placebo....

  • Tadalafil: In Pulmonary Arterial Hypertension. Croxtall, Jamie D.; Lyseng-Williamson, Katherine A. // Drugs;2010, Vol. 70 Issue 4, p479 

    Tadalafil is a selective cyclic guanosine monophosphate-specific phosphodiesterase type 5 inhibitor that is effective in improving exercise ability, the time to clinical worsening and health-related quality of life (HR-QOL) scores in patients with pulmonary arterial hypertension (PAH). In a...

  • Storm in a coffee cup: caffeine modifies brain activation to social signals of threat. Smith, Jessica E.; Lawrence, Andrew D.; Diukova, Ana; Wise, Richard G.; Rogers, Peter J. // Social Cognitive & Affective Neuroscience;Oct2012, Vol. 7 Issue 7, p831 

    Caffeine, an adenosine A1 and A2A receptor antagonist, is the most popular psychostimulant drug in the world, but it is also anxiogenic. The neural correlates of caffeine-induced anxiety are currently unknown. This study investigated the effects of caffeine on brain regions implicated in social...

  • NO BUZZ. T. E. // Joe Weider's Muscle & Fitness;Dec2008, Vol. 69 Issue 12, p57 

    The article presents research on the effect of caffeine to nitric oxide (NO). Researchers from Hiroshima University in Japan found that caffeine enhances nitric oxide (NO). They note that caffeine increased the dilation of the forearm blood vessels which enhances the amount of blood flow. This...

  • CAFFEINE AND NO BOOSTERS DON'T GET ALONG.  // Muscle & Performance;Sep2011, Vol. 3 Issue 9, p24 

    The article offers information on a study which examined the effect of caffeine on the functions of nitric-oxide boosters like arginine.

  • Improvement of erectile function with Prelox: a randomized, double-blind, placebo-controlled, crossover trial. Stanislavov, R.; Nikolova, V.; Rohdewald, P. // International Journal of Impotence Research;Mar/Apr2008, Vol. 20 Issue 2, p173 

    In a randomly allocated, double-blind, placebo-controlled, crossover design, 50 patients with mild to moderate erectile dysfunction (ED) were treated for 1 month with placebo or a combination of L-arginine aspartate and Pycnogenol (Prelox). Patients reported sexual function from diaries....

  • ‘I need my caffeine!’. Traister, Rebecca // Glamour;Oct2006, Vol. 104 Issue 10, p186 

    The article discusses the effects of caffeine on the body. Caffeine is the most widely used mood-altering drug in the world, according to psychiatry professor Roland Griffiths. This drug works primarily by blocking a chemical called adenosine, which acts as a mild sedative and helps blood...

  • Relaxation and potentiation of cGMP-mediated response by ibudilast in bovine tracheal smooth muscle. Nakahara, Tsutomu; Yunoki, Motonari; Moriuchi, Hiroshi; Mitani, Akiko; Sakamoto, Kenji; Ishii, Kunio // Naunyn-Schmiedeberg's Archives of Pharmacology;Sep2002, Vol. 366 Issue 3, p262 

    The effects of ibudilast, an inhibitor of phosphodiesterases (PDEs), on tension, levels of guanosine 3',5'-cyclic monophosphate (cGMP) and adenosine 3',5'-cyclic monophosphate (cAMP) were investigated in bovine tracheal smooth muscle. We especially examined the combined effect of ibudilast with...


Read the Article


Sign out of this library

Other Topics